FIELD: chemistry.
SUBSTANCE: invention relates to new indolylmaleimide derivatives with formula I , where: Ra is H; C1-C4alkyl; one of Rb, Rc, Rd and Re is C1-C4alkyl, and the others are H; or Rb, Re, Rd and Re are all H; and R is a radical with formula (a), (b) and (c), presented in the claim.
EFFECT: compounds inhibit protein kinase C (PKC), which allows for their use in making a medicinal agent for treating or preventing diseases or disorders mediated by T lymphocytes and/or PKC, particularly during transplantation.
8 cl, 11 tbl, 47 ex
Title | Year | Author | Number |
---|---|---|---|
USING PKC INHIBITORS IN TRANSPLANTATION | 2007 |
|
RU2494738C2 |
INDOLYLMALEIMIDE DERIVATIVES | 2005 |
|
RU2373201C2 |
PROTEINKINASE C INHIBITORS USED FOR TREATING AUTOIMMUNE DISEASES AND GRAFT REJECTION | 2005 |
|
RU2413511C2 |
COMBINATIONS CONTAININS Bcr-Abl/c-Kit/PDGF-RTK INHIBITORS FOR TREATING CANCER | 2007 |
|
RU2452492C2 |
METHOD OF SYNTHESIS OF SUBSTITUTED PYRROLS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1990 |
|
RU2014332C1 |
DERIVATIVE OF IMIDE INDOLYLMALEIC ACID AS AN INHIBITOR OF PROTEINKINASE C | 2001 |
|
RU2329263C2 |
COMPOUNDS AND COMPOSITIONS AS PROTEINKINASE INHIBITORS | 2005 |
|
RU2406725C2 |
ORGANIC COMPOUNDS | 2005 |
|
RU2379309C2 |
DERIVATIVES OF 4-AMINO-6-PHENYLPYRROLO[2,3]PYRIMIDINE POSSESSING INHIBITORY EFFECT ON TYROSINE KINASE ACTIVITY, THEIR USING AND METHODS FOR THEIR PREPARING (VARIANTS) | 2002 |
|
RU2318826C2 |
USE OF RKS INHIBITORS IN DIABETES RELATED COMPLICATIONS | 2007 |
|
RU2447892C2 |
Authors
Dates
2009-11-10—Published
2005-01-19—Filed